Align Technology | ALGN - Bénéfice Avant Impôts

Prix De L'Action
172.00
Variation Quotidienne
3.29 1.95%
Mensuellement
3.07%
Annuel
-0.13%
Q2 Prévisions
175.19




Bénéfice Avant Impôts Changement Date
3M USD 878M 119M 2026-03
Align Technology USD 148.89M 27.71M 2026-03
Becton, Dickinson and Co. USD 393M 117M 2025-12
Bruker USD -72.6M 73.1M 2025-09
Cardinal Health USD 630M 32M 2025-12
Charles River Laboratories USD 170.03M 98.62M 2025-09
Cooper Companies USD 116.8M 137.4M 2025-09
CVS Health USD 1.35B 4.84B 2025-12
Danaher USD 1.24B 138M 2026-03
Dentsply International USD -147M 83M 2025-12
Dexcom USD 340.7M 40.7M 2025-12
Henry Schein USD 133M 4M 2025-12
Idexx Laboratories USD 355.44M 48.46M 2026-03
Insulet USD 140.2M 17.4M 2025-12
Integra LifeSciences USD 4.31M 11.13M 2025-12
IQVIA Holdings USD 6.22B 5.68B 2026-03
Masimo USD 74.9M 19.5M 2025-09
McKesson USD 1.4B 344M 2025-09
Mettler Toledo International USD 269.24M 20.58M 2025-09
Revvity USD 91.56M 35.88M 2025-12
Solventum Corp USD 332M 179M 2025-12
Stryker USD 1.7B 676M 2025-12
Teleflex USD -438.58M 573.82M 2025-09
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Veeva Systems USD 436.85M 14.82M 2025-09
Waters USD 264.18M 94.06M 2025-12
Zimmer Biomet Holdings USD 98M 320.7M 2025-12
Zoetis USD 887M 15M 2025-09